Cargando…
Pharmacological approaches to the prevention of type 2 diabetes mellitus
About 1 in 10 adults worldwide are estimated to have diabetes mellitus. They are at risk of developing life-threatening complications resulting in reduced quality of life, increased mortality and higher healthcare costs. The ability to prevent or delay type 2 diabetes mellitus (T2DM) by modifying so...
Autores principales: | Majety, Priyanka, Lozada Orquera, Faustina Alejandra, Edem, Dinesh, Hamdy, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033948/ https://www.ncbi.nlm.nih.gov/pubmed/36967777 http://dx.doi.org/10.3389/fendo.2023.1118848 |
Ejemplares similares
-
The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021) -
Thyroid nodules: need for a universal risk stratification system
por: Majety, Priyanka
Publicado: (2023) -
Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches
por: Qi, Jian-hong, et al.
Publicado: (2023) -
Pharmacological Primary Prevention of Diabetes Mellitus Type II: A Narrative Review
por: Naveed, Ali, et al.
Publicado: (2020) -
Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system
por: Giagulli, VA, et al.
Publicado: (2022)